Body Composition Predicts Growth in Infants and Toddlers With Chronic Liver Disease

Erika F Hurtado-López1,2, Edgar M Vásquez-Garibay2, Xóchitl Trujillo3

  • 1Servicio de Gastroenterología y Nutrición, Unidad Médica de Alta Especialidad Hospital de Pediatría, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social.

Insights

Arm anthropometry accurately estimates body composition in infants with chronic liver disease. This method predicts growth and nutritional status, aiding clinical assessment.

Area of Science:

  • Pediatric Gastroenterology and Nutrition
  • Clinical Anthropometry and Body Composition Analysis

Background:

  • Chronic liver disease (CLD) in infants and toddlers often leads to altered body composition (BC).
  • Accurate BC assessment is crucial for monitoring nutritional status and growth in this population.
  • Traditional methods for BC assessment can be complex or inaccessible in clinical settings.

Purpose of the Study:

  • To validate arm anthropometry as an accurate measure of body composition in pediatric CLD patients.
  • To assess the predictive value of arm anthropometry for growth parameters (length, head circumference).
  • To compare arm anthropometry with dual-energy x-ray absorptiometry (DXA) for BC estimation.

Main Methods:

  • Cross-sectional study involving 15 infants and toddlers diagnosed with chronic liver disease.
  • Arm anthropometric measurements (e.g., arm adiposity indicators, arm muscle area) were taken.
  • Body composition was assessed using dual-energy x-ray absorptiometry (DXA) as the reference standard.

Main Results:

  • Arm anthropometry indicators showed significant correlation with fat mass and fat-free mass.
  • Arm adiposity indicators predicted fat mass, while arm muscle area predicted fat-free mass.
  • Bone mineral content explained 87% of the variation in length; length was predictable using fat mass, fat-free mass, and bone mineral content.

Conclusions:

  • Arm anthropometry serves as a valuable and practical tool for estimating body composition in pediatric CLD.
  • This method can effectively predict growth parameters like length and head circumference.
  • Arm anthropometry aids in assessing the nutritional status of infants and toddlers with chronic liver disease.

Related Concept Videos

Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.9K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
225
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
356